Abstract
There is ever-increasing literature pointing out that gene expression in tumour cells is different from that in normal cells from which or in which the tumour originates. In general, neoplasia is characterized by misprogramming of protein synthesis (16).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bennet, M.J., Timperley, W.R., Taylor, C.B., Hill, A.S.: Isozymes of hexokinase in the developing, normal and neoplastic human brain. Europ. J. Cancer 14, 189–193 (1978)
Deshpande, N., Mitchell, I., Millis, R.: Tumour enzymes and prognosis in human breast cancer. Europ. J. Cancer 17, 443–448 (1981)
Eigenbrodt, E., Glossmann, H.: Glycolysis — one of the keys to cancer? Trends Pharmacol. Sci. 1, 240–245 (1980)
Ibsen, K.H.: Interrelationships and functions of the pyruvate kinase isozymes and their variant forms: a review. Cancer Res. 37, 341–353 (1977)
Ibsen, K.H., Fishman, W.H.: Developmental gene expression in cancer. Biochim. Biophys. Acta Cancer Rev. 560, 243–280 (1979)
Knox, W.E., Linder, M., Friedel, G.H.: A series of transplantable rat mammary tumors with graded differentiation, growth rate and glutaminase content. Cancer Res. 30, 283–287 (1970)
Marx, J.: Tumor viruses and the kinase connection. Science 211, 1336–1338 (1981)
Rabow, L., Kristansson, K.: Changes in lactate dehydrogenase isozyme patterns in patients with tumours of the central nervous system. Acta Neurochir. 36, 71–81 (1977)
Schapira, T.: Isozymes and cancer. Advan. Cancer Res. 18, 77–153 (1973)
Tolle, S.W., Dyson, R.D., Newburgh, R.W., Cardenas, J.M.: Pyruvate kinase isozymes in neurons, glia, neuroblastoma and glioblastoma. J. Neurochem. 27, 1355–1360 (1976)
Van Veelen, C.W.M., Verbiest, H., Vlug, A.M.C., Rijksen, G., Staal, G.E.J.: Isozymes of pyruvate kinase from human brain maningiomas and malignant gliomas. Cancer Res. 38, 4681–4687 (1978)
Van Veelen, C.W.M., Verbiest, H., Zülch, K.J., van Ketel, B.A., van der Vlist, M.J.M., Vlug, A.M. C., Rijksen, G., Staal, G.E.J.: L-0-alanine inhibition of pyruvate kinase from tumors of the human central nervous system. Cancer Res. 39, 4263–4269 (1979)
Van Veelen, C.W.M., Rijksen, G., Vlug, A.M.C., Staal, G.E.J.: Correlation between alanine inhibition of pyruvate kinase and composition of K-M hybrids. Clin. Chim. Acta 110, 113–120 (1981)
Weber, G.: Enzymology of cancer cells. New. Engl. J. Med. 296, 486–493 (1977)
Weinhouse, S.: Metabolism and isozyme alterations in experimental hepatomas. Fed. Proc. 32, 2162–2167 (1973)
Weinhouse, S.: Molecular mechanism of gene regulation. Cancer 36, 4330–4331 (1976)
Weinhouse, S.: New dimensions in the biology of cancer. Cancer 45, 2975–2980 (1980)
Zülch, K.J.: Principles of the new WHO classification of brain tumors. J. Neurosurg. Sci. 22, 1–5 (1978)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
van Veelen, C.W.M. et al. (1982). L-α-Alanine Inhibition of Pyruvate Kinase from Tumours of the Human Central Nervous System. In: Brock, M. (eds) Modern Neurosurgery 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-08801-2_14
Download citation
DOI: https://doi.org/10.1007/978-3-662-08801-2_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-08803-6
Online ISBN: 978-3-662-08801-2
eBook Packages: Springer Book Archive